很自豪能与 @carisls 分享我们的研究，探讨 G protein coupled estrogen receptor 与 estrogen receptor 在 EGFR 突变 NSCLC 中的影响，结果显示 GPER 高表达和 ESR1/2 低表达与预后存在显著差异。#ESMO26 #lcsm @uscnorris
434 浏览 · 8 赞 · 2 转发 · 0 回复
Improving prevention of moderate to severe dermatologic adverse events in EGFR-mutant advanced NSCLC treated with first-line (1L) subcutaneous (SC) amivantamab + lazertinib: First results from a new COCOON cohort
https://esmocongress.esmo.orgExtended circulating tumor DNA (ctDNA) sequencing to optimize the selection between anti-EGFR rechallenge and other later lines in patients with RAS/BRAF wild-type metastatic colorectal cancer
https://esmocongress.esmo.org- **标题 / Title：** A Study of HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKI Therapy
https://esmocongress.esmo.org来源：Robert Hsu MD · x.com